Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 106 (3) , 275-281
- https://doi.org/10.1016/0304-3940(89)90176-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+Neuroscience Letters, 1989
- In vivo dopaminergic neurotoxicity of the 2-β-methylcarbolinium ion, a potential endogenous MPP+ analogEuropean Journal of Pharmacology, 1988
- Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeysEuropean Journal of Pharmacology, 1988
- Flow dependent changes in the effective surface area of microdialysis probesLife Sciences, 1988
- The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in miceEuropean Journal of Pharmacology, 1986
- Brain dialysis in conscious rats reveals an instantaneous massive release striatal dopamine in response to MPP+European Journal of Pharmacology, 1986
- 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayNature, 1986
- Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to ratsNeuroscience Letters, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratEuropean Journal of Pharmacology, 1984